Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/optimizing-current-treatment-of-gout-zX8MODNRNR
References (135)
-
N. Schlesinger, R. Alten, T. Bardin, H. Schumacher, M. Bloch, A. Gimona, G. Krammer, V. Murphy, D. Richard, A. So (2012)
Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensionsAnnals of the Rheumatic Diseases, 71
-
Karen Spencer, A. Carr, M. Doherty (2012)
Patient and provider barriers to effective management of gout in general practice: a qualitative studyAnnals of the Rheumatic Diseases, 71
-
D. Owens, B. Whelan, G. McCarthy (2008)
A survey of the management of gout in primary care.Irish medical journal, 101 5
-
Ralph Schumacher, J. Boice, D. Daikh, S. Mukhopadhyay, K. Malmstrom, J. Ng, G. Tate, J. Molina (2002)
Randomised double blind trial of etoricoxib and indometacin in treatment of acute gouty arthritisBMJ : British Medical Journal, 324
-
M. Becker, H. Schumacher, R. Wortmann, P. Macdonald, W. Palo, Denise Eustace, L. Vernillet, N. Joseph‐Ridge (2005)
Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: a twenty-eight-day, multicenter, phase II, randomized, double-blind, placebo-controlled, dose-response clinical trial examining safety and efficacy in patients with gout.Arthritis and rheumatism, 52 3
-
X. Zhu, J. Chen, F. Han, M. Cheng, L. Xu, L. Zhang, X. Ding, Y. Le (2009)
Efficacy and safety of losartan in treatment of hyperuricemia and posttransplantation erythrocytosis: results of a prospective, open, randomized, case-control study.Transplantation proceedings, 41 9
-
M. Reinders, C. Haagsma, T.L.Th.A. Jansen, Van Roon, J. Delsing, M. Laar, Jacobus Brouwers (2008)
A randomised controlled trial on the efficacy and tolerability with dose escalation of allopurinol 300–600 mg/day versus benzbromarone 100–200 mg/day in patients with goutAnnals of the Rheumatic Diseases, 68
-
Weiya Zhang, M. Doherty, T. Bardin, E. Pascual, V. Barskova, P. Conaghan, J. Gerster, J. Jacobs, B. Leeb, F. Lioté, G. McCarthy, P. Netter, G. Nuki, F. Pérez-Ruiz, A. Pignone, J. Pimentão, L. Punzi, E. Roddy, T. Uhlig, I. Zimmermann-Górska (2006)
EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee For International Clinical Studies Including Therapeutics (ESCISIT)Annals of the Rheumatic Diseases, 65
-
Ali Momeni, S. Shahidi, S. Seirafian, S. Taheri, S. Kheiri (2010)
Effect of allopurinol in decreasing proteinuria in type 2 diabetic patients.Iranian journal of kidney diseases, 4 2
-
M. Bastow, P. Durrington, M. Ishola (1988)
Hypertriglyceridemia and hyperuricemia: effects of two fibric acid derivatives (bezafibrate and fenofibrate) in a double-blind, placebo-controlled trial.Metabolism: clinical and experimental, 37 3
-
L. Stamp, J. O’Donnell, Mei Zhang, J. James, C. Frampton, M. Barclay, P. Chapman (2011)
Using allopurinol above the dose based on creatinine clearance is effective and safe in patients with chronic gout, including those with renal impairment.Arthritis and rheumatism, 63 2
-
Gregory Borstad, L. Bryant, M. Abel, D. Scroggie, M. Harris, J. Alloway (2004)
Colchicine for prophylaxis of acute flares when initiating allopurinol for chronic gouty arthritis.The Journal of rheumatology, 31 12
-
F. Pérez-Ruiz, A. Herrero-Beites, L. Carmona (2011)
A two-stage approach to the treatment of hyperuricemia in gout: the "dirty dish" hypothesis.Arthritis and rheumatism, 63 12
-
Mahesh Shrestha, David Morgan, Jody Moreden, Rajeev Singh, Mark Nelson, James Hayes (1995)
Randomized double-blind comparison of the analgesic efficacy of intramuscular ketorolac and oral indomethacin in the treatment of acute gouty arthritis.Annals of emergency medicine, 26 6
-
D. Khanna (2013)
American College of Rheumatology guidelines for management of gout, 37
-
F. Pérez-Ruiz (2009)
Treating to target: a strategy to cure gout.Rheumatology, 48 Suppl 2
-
M. Goicoechea, S. Vinuesa, Ú. Verdalles, Caridad Ruiz-Caro, J. Ampuero, A. Rincón, D. Arroyo, J. Luño (2010)
Effect of allopurinol in chronic kidney disease progression and cardiovascular risk.Clinical journal of the American Society of Nephrology : CJASN, 5 8
-
J. Scott (1966)
Comparison of allopurinol and probenecid.Annals of the rheumatic diseases, 25 6 Suppl
-
L. Harrold, K. Mazor, D. Peterson, Nausheen Naz, Cassandra Firneno, R. Yood (2012)
Patients’ knowledge and beliefs concerning gout and its treatment: a population based studyBMC Musculoskeletal Disorders, 13
-
M. Becker, H. Schumacher, R. Wortmann, P. Macdonald, Denise Eustace, W. Palo, Janet Streit, N. Joseph‐Ridge (2005)
Febuxostat compared with allopurinol in patients with hyperuricemia and gout.The New England journal of medicine, 353 23
-
L. Stamp, W. Taylor, Peter Jones, J. Dockerty, J. Drake, C. Frampton, N. Dalbeth (2012)
Starting dose is a risk factor for allopurinol hypersensitivity syndrome: a proposed safe starting dose of allopurinol.Arthritis and rheumatism, 64 8
-
M. Reinders, E. Roon, T. Jansen, J. Delsing, E. Griep, M. Hoekstra, M. Laar, J. Brouwers (2008)
Efficacy and tolerability of urate-lowering drugs in gout: a randomised controlled trial of benzbromarone versus probenecid after failure of allopurinolAnnals of the Rheumatic Diseases, 68
-
W. Doehner, N. Schoene, M. Rauchhaus, F. Leyva-Leon, D. Pavitt, D. Reaveley, G. Schuler, A. Coats, S. Anker, R. Hambrecht (2002)
Effects of Xanthine Oxidase Inhibition With Allopurinol on Endothelial Function and Peripheral Blood Flow in Hyperuricemic Patients With Chronic Heart Failure: Results From 2 Placebo-Controlled StudiesCirculation: Journal of the American Heart Association, 105
-
T. Lyngdoh, P. Vuistiner, P. Marques-Vidal, V. Rousson, G. Waeber, P. Vollenweider, M. Bochud (2012)
Serum Uric Acid and Adiposity: Deciphering Causality Using a Bidirectional Mendelian Randomization ApproachPLoS ONE, 7
-
A. So, M. Meulemeester, A. Pikhlak, A. Yücel, D. Richard, V. Murphy, U. Arulmani, P. Sallstig, N. Schlesinger (2010)
Canakinumab for the treatment of acute flares in difficult-to-treat gouty arthritis: Results of a multicenter, phase II, dose-ranging study.Arthritis and rheumatism, 62 10
-
EH Choy, GH Kingsley, B Khoshaba, N Pipitone, DL Scott (2005)
Intramuscular Methylprednisolone Study Group. A two year randomised controlled trial of intramuscular depot steroids in patients with established rheumatoid arthritis who have shown an incomplete response to disease modifying antirheumatic drugsAnn. Rheum. Dis., 64
-
Seoyoung Kim, Craig Newcomb, D. Margolis, J. Roy, S. Hennessy (2013)
Severe Cutaneous Reactions Requiring Hospitalization in Allopurinol Initiators: A Population‐Based Cohort StudyArthritis Care & Research, 65
-
R. Terkeltaub, D. Furst, J. Digiacinto, K. Kook, M. Davis (2011)
Novel evidence-based colchicine dose-reduction algorithm to predict and prevent colchicine toxicity in the presence of cytochrome P450 3A4/P-glycoprotein inhibitors.Arthritis and rheumatism, 63 8
-
E. Kaya, H. Yorgun, U. Canpolat, T. Hazırolan, H. Sunman, A. Ülgen, A. Ateş, K. Aytemir, L. Tokgözoğlu, G. Kabakçı, D. Akata, A. Oto (2010)
Serum uric acid levels predict the severity and morphology of coronary atherosclerosis detected by multidetector computed tomography.Atherosclerosis, 213 1
-
M. Hui, A. Carr, Stewart Cameron, G. Davenport, Michael, Doherty, H. Forrester, Wendy Jenkins, K. Jordan, C. Mallen, T. Mcdonald, G. Nuki, Anthony Pywell, Weiya Zhang, Edward, Roddy (2007)
British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of gout.Rheumatology, 46 8
-
Hyon Choi, K. Atkinson, E. Karlson, W. Willett, G. Curhan (2004)
Alcohol intake and risk of incident gout in men: a prospective studyThe Lancet, 363
-
M. Becker, A. Hollister, R. Terkeltaub, A. Waugh, A. Flynt, D. Fitz-Patrick, W. Sheridan (2013)
FRI0367 BCX4208 added to allopurinol increases response rates in patients with GOUT who fail to reach goal range serum uric acid on allopurinol alone: A randomized, double-blind, placebo-controlled trialAnnals of the Rheumatic Diseases, 71
-
B. Rubin, R. Burton, S. Navarra, Joseph Antigua, J. Londoño, K. Pryhuber, M. Lund, E. Chen, Daryl Najarian, R. Petruschke, Z. Ozturk, G. Geba (2004)
Efficacy and safety profile of treatment with etoricoxib 120 mg once daily compared with indomethacin 50 mg three times daily in acute gout: a randomized controlled trial.Arthritis and rheumatism, 50 2
-
W. Kuzell, L. Seebach, Richard Glover, A. Jackman (1966)
Treatment of Gout with Allopurinol and Sulphinpyrazone in Combination and with Allopurinol Alone*Annals of the Rheumatic Diseases, 25
-
Yuqing Zhang, T. Neogi, Clara Chen, C. Chaisson, D. Hunter, Hyon Choi (2012)
Cherry consumption and decreased risk of recurrent gout attacks.Arthritis and rheumatism, 64 12
-
M. Doherty, T. Jansen, G. Nuki, E. Pascual, F. Pérez-Ruiz, L. Punzi, A. So, T. Bardin (2012)
Gout: why is this curable disease so seldom cured?Annals of the Rheumatic Diseases, 71
-
C. Kuo, Kuang-Hui Yu, L. See, I. Chou, Y. Ko, Hsiao-Chun Chang, Meng‐Jiun Chiou, S. Luo (2013)
Risk of myocardial infarction among patients with gout: a nationwide population-based study.Rheumatology, 52 1
-
N. Schlesinger, M. Meulemeester, A. Pikhlak, A Yücel, D. Richard, V. Murphy, U. Arulmani, P. Sallstig, A. So (2011)
Canakinumab relieves symptoms of acute flares and improves health-related quality of life in patients with difficult-to-treat Gouty Arthritis by suppressing inflammation: results of a randomized, dose-ranging studyArthritis Research & Therapy, 13
-
Robert Terkeltaub (2009)
Colchicine update: 2008.Seminars in arthritis and rheumatism, 38 6
-
N. Dalbeth, K. Petrie, M. House, Jimmy Chong, W. Leung, Rini Chegudi, A. Horne, G. Gamble, F. McQueen, W. Taylor (2011)
Illness perceptions in patients with gout and the relationship with progression of musculoskeletal disabilityArthritis Care & Research, 63
-
F. Lioté, Hyon Choi (2013)
Managing gout needs more than drugs: ‘Il faut le savoir-faire, l'Art et la manière’Annals of the Rheumatic Diseases, 72
-
R Lederman (1990)
A double-blind comparison of etodolac and high doses of naproxen in the treatment of acute goutAdv. Ther., 7
-
N. Dalbeth, E. Gracey, B. Pool, K. Callon, F. McQueen, J. Cornish, A. MacGibbon, K. Palmano (2009)
Identification of dairy fractions with anti-inflammatory properties in models of acute goutAnnals of the Rheumatic Diseases, 69
-
D. Brater (2002)
Anti-inflammatory agents and renal function.Seminars in arthritis and rheumatism, 32 3 Suppl 1
-
A. Prasad (1994)
British National FormularyThe Psychiatrist, 18
-
G. Vincent (1970)
[Treatment of chronic gout].Journal des sciences medicales de Lille, 88 6
-
Sonali Gnanenthiran, G. Hassett, G. Hassett, Kathryn Gibson, Kathryn Gibson, H. McNeil, H. McNeil (2011)
Acute gout management during hospitalization: a need for a protocolInternal Medicine Journal, 41
-
E. Roddy, Weiya Zhang, M. Doherty (2007)
Are joints affected by gout also affected by osteoarthritis?Annals of the Rheumatic Diseases, 66
-
T. Neogi, J. George, S. Rekhraj, A. Struthers, Hyon Choi, R. Terkeltaub (2012)
Are either or both hyperuricemia and xanthine oxidase directly toxic to the vasculature? A critical appraisal.Arthritis and rheumatism, 64 2
-
N. Ganson, S. Kelly, E. Scarlett, J. Sundy, M. Hershfield (2005)
Control of hyperuricemia in subjects with refractory gout, and induction of antibody against poly(ethylene glycol) (PEG), in a phase I trial of subcutaneous PEGylated urate oxidaseArthritis Research & Therapy, 8
-
L. Stamp, Sarah Jordan (2011)
The Challenges of Gout Management in the ElderlyDrugs & Aging, 28
-
D. Khanna, P. Khanna, J. Fitzgerald, Manjit Singh, S. Bae, T. Neogi, M. Pillinger, Joan Merill, Susan Lee, Shraddha Prakash, Marian Kaldas, Maneesh Gogia, F. Pérez-Ruiz, W. Taylor, F. Lioté, Hyon Choi, J. Singh, N. Dalbeth, Sanford Kaplan, V. Niyyar, Danielle Jones, S. Yarows, B. Roessler, G. Kerr, Charles King, Gerald. Levy, D. Furst, N. Edwards, B. Mandell, H. Schumacher, Mark Robbins, N. Wenger, R. Terkeltaub (2012)
2012 American College of Rheumatology guidelines for management of gout. Part 2: Therapy and antiinflammatory prophylaxis of acute gouty arthritisArthritis Care & Research, 64
-
R. Wortmann, P. Macdonald, B. Hunt, R. Jackson (2010)
Effect of prophylaxis on gout flares after the initiation of urate-lowering therapy: analysis of data from three phase III trials.Clinical therapeutics, 32 14
-
A. Stack, A. Hanley, L. Casserly, C. Cronin, A. Abdalla, T. Kiernan, B. Murthy, A. Hegarty, A. Hannigan, H. Nguyen (2013)
Independent and conjoint associations of gout and hyperuricaemia with total and cardiovascular mortality.QJM : monthly journal of the Association of Physicians, 106 7
-
S. Chohan (2011)
Safety and Efficacy of Febuxostat Treatment in Subjects with Gout and Severe Allopurinol Adverse ReactionsThe Journal of Rheumatology, 38
-
Li-Chia Chen, D. Ashcroft (2007)
Risk of myocardial infarction associated with selective COX‐2 inhibitors: Meta‐analysis of randomised controlled trialsPharmacoepidemiology and Drug Safety, 16
-
J. Sundy, M. Becker, W. White (2011)
Pegloticase and Chronic Gout—ReplyJAMA, 306
-
A. So, T. Smedt, S. Revaz, J. Tschopp (2007)
A pilot study of IL-1 inhibition by anakinra in acute goutArthritis Research & Therapy, 9
-
M. Reinders, E. Roon, P. Houtman, J. Brouwers, T. Jansen (2007)
Biochemical effectiveness of allopurinol and allopurinol-probenecid in previously benzbromarone-treated gout patientsClinical Rheumatology, 26
-
Changgui Li, M. Hsieh, Shun-Jen Chang (2013)
Metabolic syndrome, diabetes, and hyperuricemiaCurrent Opinion in Rheumatology, 25
-
L. Stamp, J. O’Donnell, C. Frampton, J. Drake, Mei Zhang, P. Chapman (2013)
Clinically insignificant effect of supplemental vitamin C on serum urate in patients with gout: a pilot randomized controlled trial.Arthritis and rheumatism, 65 6
-
R. Butler, D. Goddard, C. Higgens, P. Hollingworth, C. Pease, M. Stodell, J. Scott (1985)
Double-blind trial of flurbiprofen and phenylbutazone in acute gouty arthritis.British journal of clinical pharmacology, 20 5
-
T. Taylor, John Mecchella, R. Larson, Kevin Kerin, T. Mackenzie (2012)
Initiation of allopurinol at first medical contact for acute attacks of gout: a randomized clinical trial.The American journal of medicine, 125 11
-
E. Choy, G. Kingsley, B. Khoshaba, N. Pipitone, D. Scott (2005)
A two year randomised controlled trial of intramuscular depot steroids in patients with established rheumatoid arthritis who have shown an incomplete response to disease modifying antirheumatic drugsAnnals of the Rheumatic Diseases, 64
-
Bullock Pw, Scott Jt (1989)
Intermittent control of hyperuricemia in the treatment of gout.The Journal of Rheumatology, 16
-
N. Dalbeth, Sunil Kumar, L. Stamp, P. Gow (2006)
Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout.The Journal of rheumatology, 33 8
-
Hyon Choi, L. Soriano, Yuqing Zhang, Luis Rodriguez (2012)
Antihypertensive drugs and risk of incident gout among patients with hypertension: population based case-control studyThe BMJ, 344
-
Roy Altman, S. Honig, J. Levin, R. Lightfoot (1988)
Ketoprofen versus indomethacin in patients with acute gouty arthritis: a multicenter, double blind comparative study.The Journal of rheumatology, 15 9
-
E. Miguel, J. Puig, C. Castillo, D. Peiteado, R. Torres, E. Martı́n-Mola (2011)
Diagnosis of gout in patients with asymptomatic hyperuricaemia: a pilot ultrasound studyAnnals of the Rheumatic Diseases, 71
-
I Garcia de la Torre (1987)
Double-blind parallel study comparing tenoxicam and placebo in acute gouty arthritis [Spanish]Invet. Med. Int., 14
-
W. Choi, E. Ford, G. Curhan, J. Rankin, Hyon Choi (2012)
Independent association of serum retinol and β‐carotene levels with hyperuricemia: A national population studyArthritis Care & Research, 64
-
T. Palmer, B. Nordestgaard, M. Benn, A. Tybjærg‐Hansen, G. Smith, D. Lawlor, N. Timpson (2013)
Association of plasma uric acid with ischaemic heart disease and blood pressure: mendelian randomisation analysis of two large cohortsThe BMJ, 347
-
M. Malaguarnera, M. Vacante, C. Russo, G. Dipasquale, Maria Gargante, M. Motta (2009)
A single dose of rasburicase in elderly patients with hyperuricaemia reduces serum uric acid levels and improves renal functionExpert Opinion on Pharmacotherapy, 10
-
Han-Yao Huang, L. Appel, M. Choi, A. Gelber, J. Charleston, E. Norkus, E. Miller (2005)
The effects of vitamin C supplementation on serum concentrations of uric acid: results of a randomized controlled trial.Arthritis and rheumatism, 52 6
-
T. Mikuls, J. Farrar, W. Bilker, S. Fernandes, H. Schumacher, K. Saag (2005)
Gout epidemiology: results from the UK General Practice Research Database, 1990–1999Annals of the Rheumatic Diseases, 64
-
B Lasko (2009)
RDEA594, a novel uricosuric agent, significantly reduced serum urate levels and was well tolerated in a phase 2a pilot study in hyperuricemic gout patients [abstract]Arthritis Rheum., 60
-
E. Roddy, Weiya Zhang, M. Doherty (2007)
Concordance of the management of chronic gout in a UK primary-care population with the EULAR gout recommendationsAnnals of the Rheumatic Diseases, 66
-
Armando Maccagno, E. Giorgio, Alberto Romanowicz (1991)
Effectiveness of etodolac ('Lodine') compared with naproxen in patients with acute gout.Current medical research and opinion, 12 7
-
P. Richette, Claire Brière, Virginie Hoenen-Clavert, D. Loeuille, T. Bardin (2007)
Rasburicase for tophaceous gout not treatable with allopurinol: an exploratory study.The Journal of rheumatology, 34 10
-
S. Yeo (2013)
HLA‐B*5801: utility and cost‐effectiveness in the Asia‐Pacific RegionInternational Journal of Rheumatic Diseases, 16
-
Takeyuki Numata, N. Miyatake, J. Wada, H. Makino (2008)
Comparison of serum uric acid levels between Japanese with and without metabolic syndrome.Diabetes research and clinical practice, 80 1
-
G. Gambaro, M. Perazella (2003)
Adverse renal effects of anti‐inflammatory agents: evaluation of selective and nonselective cyclooxygenase inhibitorsJournal of Internal Medicine, 253
-
E. Roddy, C. Mallen, S. Hider, K. Jordan (2010)
Prescription and comorbidity screening following consultation for acute gout in primary care.Rheumatology, 49 1
-
Hyon Choi, K. Atkinson, E. Karlson, W. Willett, G. Curhan (2004)
Purine-rich foods, dairy and protein intake, and the risk of gout in men.The New England journal of medicine, 350 11
-
L. Joosten, M. Netea, E. Mylona, M. Koenders, R. Malireddi, M. Oosting, R. Stienstra, F. Veerdonk, A. Stalenhoef, E. Giamarellos‐Bourboulis, T. Kanneganti, J. Meer (2010)
Engagement of fatty acids with Toll-like receptor 2 drives interleukin-1β production via the ASC/caspase 1 pathway in monosodium urate monohydrate crystal-induced gouty arthritis.Arthritis and rheumatism, 62 11
-
H. Schumacher, J. Sundy, R. Terkeltaub, Howard Knapp, S. Mellis, N. Stahl, G. Yancopoulos, Y. Soo, Shirletta King-Davis, Steven Weinstein, Allen Radin (2012)
Rilonacept (interleukin-1 trap) in the prevention of acute gout flares during initiation of urate-lowering therapy: results of a phase II randomized, double-blind, placebo-controlled trial.Arthritis and rheumatism, 64 3
-
AM Abeles (2012)
Febuxostat hypersensitivityJ. Rheumatol., 39
-
Hyon Choi, K. Atkinson, E. Karlson, G. Curhan (2005)
Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study.Archives of internal medicine, 165 7
-
H. Janssens, M. Janssen, E. Lisdonk, P. Riel, C. Weel (2008)
Use of oral prednisolone or naproxen for the treatment of gout arthritis: a double-blind, randomised equivalence trialThe Lancet, 371
-
C. Pineda, L. Amezcua-Guerra, C. Solano, P. Rodríguez-Henríquez, C. Hernández-Diaz, A. Vargas, Fritz Hofmann, M. Gutierrez (2011)
Joint and tendon subclinical involvement suggestive of gouty arthritis in asymptomatic hyperuricemia: an ultrasound controlled studyArthritis Research & Therapy, 13
-
C. Fernández, R. Noguera, González Ja, Eliseo Pascual (1999)
Treatment of acute attacks of gout with a small dose of intraarticular triamcinolone acetonide.The Journal of rheumatology, 26 10
-
J. Sundy, H. Baraf, R. Yood, N. Edwards, S. Gutiérrez-Ureña, E. Treadwell, J. Vázquez-Mellado, W. White, P. Lipsky, Zeb Horowitz, William Huang, A. Maroli, R. Waltrip, S. Hamburger, M. Becker (2011)
Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials.JAMA, 306 7
-
J. Vázquez-Mellado, E. Morales, C. Pacheco-Tena, R. Burgos-Vargas (2001)
Relation between adverse events associated with allopurinol and renal function in patients with goutAnnals of the Rheumatic Diseases, 60
-
K. Ogino, Masahiko Kato, Y. Furuse, Y. Kinugasa, Katsunori Ishida, S. Osaki, T. Kinugawa, O. Igawa, I. Hisatome, C. Shigemasa, S. Anker, W. Doehner (2010)
Uric Acid-Lowering Treatment With Benzbromarone in Patients With Heart Failure: A Double-Blind Placebo-Controlled Crossover Preliminary StudyCirculation: Heart Failure, 3
-
C. Kuo, M. Grainge, C. Mallen, Weiya Zhang, M. Doherty (2014)
Rising burden of gout in the UK but continuing suboptimal management: a nationwide population studyAnnals of the Rheumatic Diseases, 74
-
N. Schlesinger, M. Detry, B. Holland, D. Baker, A. Beutler, M. Rull, B. Hoffman, H. Schumacher (2002)
Local ice therapy during bouts of acute gouty arthritis.The Journal of rheumatology, 29 2
-
S. Juraschek, E. Miller, A. Gelber (2011)
Effect of oral vitamin C supplementation on serum uric acid: A meta‐analysis of randomized controlled trialsArthritis Care & Research, 63
-
P. Grayson, S. Kim, M. Lavalley, Hyon Choi (2011)
Hyperuricemia and incident hypertension: A systematic review and meta‐analysisArthritis Care & Research, 63
-
C. Pui, H. Mahmoud, J. Wiley, G. Woods, G. Leverger, B. Camitta, C. Hastings, S. Blaney, M. Relling, G. Reaman (2001)
Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients With leukemia or lymphoma.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 19 3
-
E. Pascual (1991)
Persistence of monosodium urate crystals and low-grade inflammation in the synovial fluid of patients with untreated gout.Arthritis and rheumatism, 34 2
-
T. Mikuls, John Farrar, Warren Bilker, S. Fernandes, K. Saag (2005)
Suboptimal physician adherence to quality indicators for the management of gout and asymptomatic hyperuricaemia: results from the UK General Practice Research Database (GPRD).Rheumatology, 44 8
-
K. Lindsay, P. Gow, J. Vanderpyl, P. Logo, N. Dalbeth (2011)
The Experience and Impact of Living With Gout: A Study of Men With Chronic Gout Using a Qualitative Grounded Theory ApproachJournal of Clinical Rheumatology, 17
-
L. Harrold, K. Mazor, A. Negrón, J. Ogarek, Cassandra Firneno, R. Yood (2013)
Primary care providers' knowledge, beliefs and treatment practices for gout: results of a physician questionnaire.Rheumatology, 52 9
-
H. Schumacher, R. Evans, K. Saag, James Clower, W. Jennings, S. Weinstein, G. Yancopoulos, Jian Wang, R. Terkeltaub (2012)
Rilonacept (interleukin‐1 trap) for prevention of gout flares during initiation of uric acid–lowering therapy: Results from a phase III randomized, double‐blind, placebo‐controlled, confirmatory efficacy studyArthritis Care & Research, 64
-
R. Terkeltaub, D. Furst, K. Bennett, K. Kook, R. Crockett, M. Davis (2010)
High versus low dosing of oral colchicine for early acute gout flare: Twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study.Arthritis and rheumatism, 62 4
-
I. Holme, A. Aastveit, N. Hammar, N. Hammar, I. Jungner, G. Walldius, G. Walldius (2009)
Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417 734 men and women in the Apolipoprotein MOrtality RISk study (AMORIS)Journal of Internal Medicine, 266
-
Yanyan Zhu, Bhavik Pandya, Hyon Choi (2011)
Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008.Arthritis and rheumatism, 63 10
-
Ming-Han Lee, G. Graham, K. Williams, R. Day (2008)
A Benefit-Risk Assessment of Benzbromarone in the Treatment of GoutDrug Safety, 31
-
A. Noman, D. Ang, S. Ogston, C. Lang, A. Struthers (2010)
Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trialLancet, 375
-
Michael Ahern, C. Reid, T. Gordon, M. McCREDlE, P. Brooks, M. Jones (1987)
Does colchicine work? The results of the first controlled study in acute gout.Australian and New Zealand journal of medicine, 17 3
-
S. DeAngelis, A. Noce, L. DiRenzo, Rossella Cianci, A. Naticchia, Giarrizzo Gf, F. Giordano, C. Tozzo, Giorgio Splendiani, A. DeLorenzo (2007)
Is rasburicase an effective alternative to allopurinol for management of hyperuricemia in renal failure patients? A double blind-randomized study.European review for medical and pharmacological sciences, 11 3
-
G. Cattermole, C. Man, Chi-hung Cheng, C. Graham, T. Rainer (2009)
Oral prednisolone is more cost-effective than oral indomethacin for treating patients with acute gout-like arthritisEuropean Journal of Emergency Medicine, 16
-
N. Dalbeth, R. Ames, G. Gamble, A. Horne, Sumwai Wong, B. Kuhn-Sherlock, A. MacGibbon, F. McQueen, I. Reid, K. Palmano (2012)
Effects of skim milk powder enriched with glycomacropeptide and G600 milk fat extract on frequency of gout flares: a proof-of-concept randomised controlled trialAnnals of the Rheumatic Diseases, 71
-
D. Khanna, J. Fitzgerald, P. Khanna, S. Bae, Manjit Singh, T. Neogi, M. Pillinger, Joan Merill, Susan Lee, Shraddha Prakash, Marian Kaldas, Maneesh Gogia, F. Pérez-Ruiz, W. Taylor, F. Lioté, Hyon Choi, J. Singh, N. Dalbeth, Sanford Kaplan, V. Niyyar, Danielle Jones, S. Yarows, B. Roessler, G. Kerr, Charles King, Gerald. Levy, D. Furst, N. Edwards, B. Mandell, H. Schumacher, Mark Robbins, N. Wenger, R. Terkeltaub (2012)
2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemiaArthritis Care & Research, 64
-
L. Stamp, P. Chapman (2013)
Gout and its comorbidities: implications for therapy.Rheumatology, 52 1
-
F. Rees, Wendy Jenkins, M. Doherty (2012)
Patients with gout adhere to curative treatment if informed appropriately: proof-of-concept observational studyAnnals of the Rheumatic Diseases, 72
-
S. Jolly, M. Mete, Hong Wang, Jianhui Zhu, S. Ebbesson, V. Voruganti, Anthony Comuzzie, B. Howard, J. Umans (2012)
Uric Acid, Hypertension, and Chronic Kidney Disease Among Alaska Eskimos: The Genetics of Coronary Artery Disease in Alaska Natives (GOCADAN) StudyThe Journal of Clinical Hypertension, 14
-
E. Oliveira, R. Burini (2012)
High plasma uric acid concentration: causes and consequencesDiabetology & Metabolic Syndrome, 4
-
MJ Ahern (1987)
Does colchicine work? The results of the first controlled study in acute goutAust. NZ J. Med., 17
-
Hyon Choi, Lindsay Burns, K. Shojania, Nicole Koenig, G. Reid, M. Abufayyah, G. Law, A. Kydd, H. Ouellette, S. Nicolaou (2012)
Dual energy CT in gout: a prospective validation studyAnnals of the Rheumatic Diseases, 71
-
Kun Chen, T. Fields, C. Mancuso, A. Bass, Lisa Vasanth (2010)
Anakinra's efficacy is variable in refractory gout: report of ten cases.Seminars in arthritis and rheumatism, 40 3
-
Hyon Choi, G. Curhan (2008)
Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort studyBMJ : British Medical Journal, 336
-
J. Li-Yu, G. Clayburne, M. Sieck, Anna Beutler, Marina Rull, E. Eisner, H. Schumacher (2001)
Treatment of chronic gout. Can we determine when urate stores are depleted enough to prevent attacks of gout?The Journal of rheumatology, 28 3
-
C. Man, I. Cheung, P. Cameron, T. Rainer (2007)
Comparison of Oral Prednisolone/Paracetamol and Oral Indomethacin/Paracetamol Combination Therapy in the Treatment of Acute Goutlike Arthritis: A Double-Blind, Randomized, Controlled TrialAnnals of Emergency Medicine, 49
-
MH Lee, GG Graham, KM Williams, RO Day (2008)
A benefit-risk assessment of benzbromarone in the treatment of gout. Was its withdrawal from the market in the best interest of patients?Drug Saf., 31
-
R. Terkeltaub, J. Sundy, H. Schumacher, F. Murphy, S. Bookbinder, S. Biedermann, R. Wu, S. Mellis, A. Radin (2009)
The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot studyAnnals of the Rheumatic Diseases, 68
-
J. Alloway, M. Moriarty, Y. Hoogland, D. Nashel (1993)
Comparison of triamcinolone acetonide with indomethacin in the treatment of acute gouty arthritis.The Journal of rheumatology, 20 1
-
D. Clive (2000)
Renal transplant-associated hyperuricemia and gout.Journal of the American Society of Nephrology : JASN, 11 5
-
P. Courtney, M. Doherty (2009)
Joint aspiration and injection and synovial fluid analysis.Best practice & research. Clinical rheumatology, 27 2
-
F. Pérez-Ruiz, I. Hernando, I. Villar, J. Nolla (2005)
Correction of Allopurinol Dosing Should Be Based on Clearance of Creatinine, but Not Plasma Creatinine Levels: Another Insight to Allopurinol-Related ToxicityJCR: Journal of Clinical Rheumatology, 11
-
F. Pérez-Ruiz, M. Calabozo, J. Pijoan, A. Herrero-Beites, A. Ruibal (2002)
Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout.Arthritis and rheumatism, 47 4
-
M. Becker, H. Schumacher, L. Espinoza, A. Wells, P. Macdonald, E. Lloyd, C. Lademacher (2010)
The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trialArthritis Research & Therapy, 12
-
A. Wertheimer, M. Davis, T. Lauterio (2011)
A new perspective on the pharmacoeconomics of colchicineCurrent Medical Research and Opinion, 27
-
H. Schumacher, M. Becker, R. Wortmann, P. Macdonald, B. Hunt, Janet Streit, C. Lademacher, N. Joseph‐Ridge (2008)
Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.Arthritis and rheumatism, 59 11
-
E Pascual (1991)
Persistence of monosodium urate crystals and low grade inflammation in the synovial fluid of untreated goutArthritis Rheum., 34
- Publisher
- Springer Journals
- Copyright
- Copyright © 2014 by Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.
- Subject
- Medicine & Public Health; Medicine/Public Health, general; Rheumatology
- ISSN
- 1759-4790
- eISSN
- 1759-4804
- DOI
- 10.1038/nrrheum.2014.32
- Publisher site
- See Article on Publisher Site
Abstract
Many established treatments are already available for managing gout effectively Lowering serum uric acid to a target level below the saturation point for urate can effectively 'cure' gout Health professionals need to be aware of current best practice for the management of gout Patient education and discussion of illness perceptions is key to addressing patient-specific risk factors and ensuring adherence to an individualized management plan Shared decision-making between a fully informed patient and a health practitioner, whether a doctor, nurse or pharmacist, can greatly increase the likelihood of a 'cure' and lead to improvements in patient outcomes
Journal
Nature Reviews Rheumatology – Springer Journals
Published: Mar 11, 2014